Q1'26 earnings miss on cost ramp-up, but all segments displayed stronger growth than expected. PT is unchanged at €11, and we reiterate our BUY rating.
22 May 2026
Q1 miss on cost ramp up, but fundamentals remain intact
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Q1 miss on cost ramp up, but fundamentals remain intact
Q1'26 earnings miss on cost ramp-up, but all segments displayed stronger growth than expected. PT is unchanged at €11, and we reiterate our BUY rating.